Page 1

TransMedics NASDAQ • TMDX The End of Transplant Waiting List Portable warm perfusion technology . A national service & logistics network . A command - and - control platform . One purpose - every viable organ , every patient , every time Waleed Hassanein , MD Founder , President & Chief Executive Officer September 2026 86 % COMPOUNDING GROWTH 86 % CAGR since FY22 + $ 140M PROVEN PROFITABILITY $ 140M swing to profit 4 MULTI - ORGAN PLATFORM 3 FDA - approved , 1 in development